The aim of this retrospective study was to evaluate the relationship between advanced imaging parameters such as prostate PSMA tumor volume and the presence of metastatic disease in newly diagnosed prostate cancer patients undergoing PSMA-PET/CT for staging purposes. The gene discussed is FOLH1; the disease is prostate carcinoma.